Free to Breathe has a new funding opportunity solely focused on research to prevent or stop lung cancer metastasis. We seek to support high-impact and innovative lung cancer research within this area of emphasis that will result in clinical translation (e.g. clinical trial) by the end of the 3-year award period. Our ultimate goal is to fund research that will result in treatments for lung cancer patients and increase survival. For 2015, we expect to support up to three $600,000 awards, paid over 3 years.
Free to Breathe will only consider Letters of Intent proposing research to prevent or stop lung cancer metastasis including a clear vision and plan for clinical translation within three years.
We are interested in (but are not limited to) proposals with:
At the time of application, the PIs must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent), and be independent investigators at or above the level of Assistant Professor (or equivalent). Sponsoring institutions must be not-for-profit institutions located within the United States.
View the Request for Proposals for more details about eligibility and application instructions.
Letter of Intent must be submitted through the online grant portal.
For questions, please contact Alice Yuroff, PhD, Senior Programs Manager.
@2014 Free To Breathe | All rights reserved.